ACETYLATOR PHENOTYPING VIA ANALYSIS OF 4 CAFFEINE METABOLITES IN HUMAN URINE BY MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY WITH MULTIWAVELENGTH DETECTION

被引:28
作者
GUO, R
THORMANN, W
机构
[1] UNIV BERN,DEPT CLIN PHARMACOL,CH-3010 BERN,SWITZERLAND
[2] SHANDONG MED UNIV,PHARM AFFILIATED HOSP,JINAN 250012,PEOPLES R CHINA
关键词
D O I
10.1002/elps.1150140183
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The simultaneous analysis of 5-acetylamino-6-formylamino-3-methyluracil (AFMU), 5-acetylamino-6-amino-3-methyluracil (AAMU), 1-methylxanthine (1X) and 1-methyluric acid (1U), the four urinary metabolites of caffeine employed for acetylator phenotyping in man, by micellar electrokinetic capillary chromatography (MECC) is reported. Using on-column fast scanning multiwavelength detection is shown to permit unambiguous identification of AAMU, AFMU, 1X and 1U in the three-dimensional electropherograms obtained with both direct urine injection or application of extracted urine. The phenotype status of a number of healthy volunteers, some with known acetylator status, were determined using peak height ratios of AFMU/1X, (AFMU + AAMU)/1X and compared to those obtained by high performance liquid chromatography (HPLC) employing the AFMU/1X peak height ratio. Another set of MECC data was obtained after deliberate conversion of AFMU to AAMU, the results being expressed by AAMU/1X, AAMU/(1U + 1X) or AAMU/(AAMU + 1U + 1X) ratios. The data suggest that most reliable data are obtained when phenotyping is conducted under conditions of complete conversion of AFMU to AAMU. Phenotyping employing caffeine and analysis of its urinary metabolites by MECC is shown to be simple and, with automated instruments, potentially suitable for routine use and large-scale population analysis. The agreement of MECC data obtained from three different instruments demonstrates the high level of maturity of this emerging technology.
引用
收藏
页码:547 / 553
页数:7
相关论文
共 12 条
[1]   GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS [J].
CLARK, DWJ .
DRUGS, 1985, 29 (04) :342-375
[2]  
ELYAZIGI A, 1989, CLIN CHEM, V35, P848
[3]  
EVANS D A P, 1969, Journal of Medical Genetics, V6, P405, DOI 10.1136/jmg.6.4.405
[4]   VARIABILITY IN CAFFEINE METABOLISM [J].
GRANT, DM ;
TANG, BK ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (05) :591-602
[5]   A SIMPLE TEST FOR ACETYLATOR PHENOTYPE USING CAFFEINE [J].
GRANT, DM ;
TANG, BK ;
KALOW, W .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (04) :459-464
[6]   OVERNIGHT SALIVARY CAFFEINE CLEARANCE - A LIVER-FUNCTION TEST SUITABLE FOR ROUTINE USE [J].
JOST, G ;
WAHLLANDER, A ;
VONMANDACH, U ;
PREISIG, R .
HEPATOLOGY, 1987, 7 (02) :338-344
[7]   HUMAN N-ACETYLATION GENOTYPE DETERMINATION WITH URINARY CAFFEINE METABOLITES [J].
KILBANE, AJ ;
SILBART, LK ;
MANIS, M ;
BEITINS, IZ ;
WEBER, WW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (04) :470-477
[8]   DETERMINATION OF N-ACETYLATOR PHENOTYPE USING CAFFEINE AS A PROBE COMPOUND - A COMPARISON OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND CAPILLARY ELECTROPHORESIS METHODS [J].
LLOYD, DK ;
FRIED, K ;
WAINER, IW .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 578 (02) :283-291
[9]  
REIDENBERG MM, 1989, BR J CLIN PHARM, V28, P207
[10]   DETERMINATION OF ACETYLATED CAFFEINE METABOLITES BY HIGH-PERFORMANCE EXCLUSION CHROMATOGRAPHY [J].
TANG, BK ;
ZUBOVITS, T ;
KALOW, W .
JOURNAL OF CHROMATOGRAPHY, 1986, 375 (01) :170-173